Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.

The results of several genome-wide association studies (GWASs) in the field of Alzheimer's disease (AD) have recently been published. Although these studies reported in detail on single-nucleotide polymorphisms (SNPs) and the neighboring genes with the strongest evidence of association with AD, little attention was paid to the rest of the genome. However, complementary statistical and bio-informatics approaches now enable the extraction of pertinent information from other SNPs and/or genes which are only nominally associated with the disease risk. Two different tools (the ALIGATOR and GenGen/KEGG software packages) were used to analyze a large GWAS dataset containing 2,032 AD cases and 5,328 controls. Convergent outputs from the two gene set enrichment approaches suggested an immune system dysfunction in AD. Furthermore, although these statistical approaches did not adopt a priori hypotheses concerning a biological function's putative role in the disease process, genes associated with AD risk were overrepresented in the "Alzheimer's disease" KEGG pathway. In conclusion, a systematic search for biological pathways using GWAS data set seems to comfort the primary causes already suspected but may specifically highlight the importance of the immune system in AD.

[1]  C. S. Lai,et al.  Temporal relationship of autophagy and apoptosis in neurons challenged by low molecular weight β-amyloid peptide , 2009, Journal of cellular and molecular medicine.

[2]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[3]  Philippe Amouyel,et al.  The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. , 2010, Trends in genetics : TIG.

[4]  S. DeKosky,et al.  Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease , 2009, Molecular Psychiatry.

[5]  P. Wong,et al.  The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential , 2009, The Journal of Neuroscience.

[6]  A. Rami.  Review: Autophagy in neurodegeneration: firefighter and/or incendiarist? , 2009, Neuropathology and applied neurobiology.

[7]  J. Prechl,et al.  Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. , 2009, Molecular immunology.

[8]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[9]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[10]  Laura J. Scott,et al.  Correction: Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution , 2009, PLoS Genetics.

[11]  Peter Kraft,et al.  Complex diseases, complex genes: keeping pathways on the right track. , 2009, Epidemiology.

[12]  C. Wijmenga,et al.  Using genome‐wide pathway analysis to unravel the etiology of complex diseases , 2009, Genetic epidemiology.

[13]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[14]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[15]  D. Small.  Dysregulation of Calcium Homeostasis in Alzheimer’s Disease , 2009, Neurochemical Research.

[16]  David C. Wilson,et al.  Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. , 2009, American journal of human genetics.

[17]  I. Ferrer,et al.  Autoantibodies against β‐amyloid are common in Alzheimer's disease and help control plaque burden , 2009, Annals of neurology.

[18]  Hartwig Wolburg,et al.  Choroid plexus: biology and pathology , 2009, Acta Neuropathologica.

[19]  F. Pasquier,et al.  A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.

[20]  K. Dolinski,et al.  Use and misuse of the gene ontology annotations , 2008, Nature Reviews Genetics.

[21]  Joseph Lau,et al.  Trends in meta-analysis of genetic association studies , 2008, Journal of Human Genetics.

[22]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[23]  Ralph A. Nixon,et al.  Autophagy, amyloidogenesis and Alzheimer disease , 2007, Journal of Cell Science.

[24]  Kai Wang,et al.  Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.

[25]  Gary K. Chen,et al.  Enriching the analysis of genomewide association studies with hierarchical modeling. , 2007, American journal of human genetics.

[26]  P. Agostinho,et al.  Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasis , 2007, Brain Research.

[27]  V. Hachinski,et al.  A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers , 2007, Neurobiology of Aging.

[28]  A. Rickinson,et al.  Antigens and Autophagy: The Path Less Travelled? , 2007, Autophagy.

[29]  Theo Hagg,et al.  The ADAMs family: Coordinators of nervous system development, plasticity and repair , 2006, Progress in Neurobiology.

[30]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[31]  L. Tjernberg,et al.  Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease , 2005, The Journal of cell biology.

[32]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Campion,et al.  Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update , 2005, Journal of Medical Genetics.

[34]  N. Bogdanovic,et al.  Human monoclonal antibodies against amyloid-beta from healthy adults , 2005, Neurobiology of Aging.

[35]  C. Caruso,et al.  Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal , 2004, Experimental Gerontology.

[36]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[37]  P. Gasque,et al.  Differential expression of individual complement regulators in the brain and choroid plexus. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[38]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.